The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Plans for filing an IND was agreed with the FDA in a recent meeting – – Positive preclinical results of the small-diameter ATEV were recently presented at The American Hea ...

said Laura Niklason ... ATEV in the vascular trauma indication was approved by the FDA in December 2024. Preclinical development is also underway in coronary artery bypass grafts, pediatric ...

This innovation could provide a much-needed off-the-shelf alternative to traditional grafts, potentially improving ... of the sdATEV in CABG," said Laura Niklason, Founder and CEO of Humacyte.

“We are excited to grow our pipeline by advancing the development of the BVP, an advanced tissue and organ system,” said Laura Niklason ... for use as a vascular conduit for extremity arterial ...